##gff-version 3
Q8NCK7	UniProtKB	Chain	1	471	.	.	.	ID=PRO_0000286673;Note=Monocarboxylate transporter 11	
Q8NCK7	UniProtKB	Topological domain	1	35	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:24390345;Dbxref=PMID:24390345	
Q8NCK7	UniProtKB	Transmembrane	36	56	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Transmembrane	78	98	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Transmembrane	106	126	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Transmembrane	131	151	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Transmembrane	163	183	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Transmembrane	198	218	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Transmembrane	243	263	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Transmembrane	273	293	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Transmembrane	312	332	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Transmembrane	333	353	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Transmembrane	367	389	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Transmembrane	407	427	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCK7	UniProtKB	Topological domain	428	471	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:24390345;Dbxref=PMID:24390345	
Q8NCK7	UniProtKB	Region	1	31	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
Q8NCK7	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_070544;Note=Risk factor for T2D when associated with G-127%2C S-340 and T-443%3B reduced pyruvate transmembrane transporter activity%2C loss of interaction with BSG and decreased localization to plasma membrane when associated with G-127%2C S-340 and T-443. V->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24390345,ECO:0000269|PubMed:28666119;Dbxref=dbSNP:rs117767867,PMID:24390345,PMID:28666119	
Q8NCK7	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_032157;Note=Risk factor for T2D when associated with I-113%2C S-340 and T-443%3B reduced pyruvate transmembrane transporter activity%2C loss of interaction with BSG and decreased localization to plasma membrane when associated with I-113%2C S-340 and T-443. D->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24390345,ECO:0000269|PubMed:28666119;Dbxref=dbSNP:rs13342692,PMID:24390345,PMID:28666119	
Q8NCK7	UniProtKB	Natural variant	340	340	.	.	.	ID=VAR_070545;Note=Risk factor for T2D when associated with I-113%2C G-127 and T-443%3B reduced pyruvate transmembrane transporter activity%2C loss of interaction with BSG and decreased localization to plasma membrane when associated with I-113%2C G-127 and T-443. G->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24390345,ECO:0000269|PubMed:28666119;Dbxref=dbSNP:rs75418188,PMID:24390345,PMID:28666119	
Q8NCK7	UniProtKB	Natural variant	443	443	.	.	.	ID=VAR_070546;Note=Risk factor for T2D when associated with I-113%2C G-127 and S-340%3B reduced pyruvate transmembrane transporter activity%2C loss of interaction with BSG and decreased localization to plasma membrane when associated with I-113%2C G-127 and S-340. P->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24390345,ECO:0000269|PubMed:28666119;Dbxref=dbSNP:rs75493593,PMID:24390345,PMID:28666119